ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

HALO Halozyme Therapeutics Incorporated

43.08
-0.74 (-1.69%)
May 28 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Halozyme Therapeutics Incorporated HALO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.74 -1.69% 43.08 20:00:00
Open Price Low Price High Price Close Price Prev Close
43.80 42.69 43.965 43.08 43.82
more quote information »

Recent News

Date Time Source Heading
5/22/202417:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/22/202416:08EDGAR2Form 144 - Report of proposed sale of securities
5/21/202416:00EDGAR2Form 144 - Report of proposed sale of securities
5/21/202407:15PRNUSHalozyme Announces Bristol Myers Squibb Received Updated..
5/08/202408:30PRNUSHalozyme to Participate in Upcoming Investor Conferences
5/07/202416:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/07/202416:05EDGAR2Form 8-K - Current report
5/07/202416:01PRNUSHALOZYME REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING..
4/25/202416:45PRNUSMahesh Krishnan Elected to Halozyme's Board of Directors
4/23/202408:30PRNUSHalozyme to Report First Quarter 2024 Financial and..
3/04/202416:13EDGAR2Form PRE 14A - Other preliminary proxy statements
2/28/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/28/202416:07EDGAR2Form 144 - Report of proposed sale of securities
2/27/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202416:08EDGAR2Form 144 - Report of proposed sale of securities
2/27/202408:30PRNUSHalozyme to Participate in Upcoming Investor Conferences
2/20/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202418:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202416:07EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/202416:03EDGAR2Form 8-K - Current report
2/20/202416:01PRNUSHALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
2/16/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202417:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202416:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202406:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/08/202416:30PRNUSHalozyme To Report Fourth Quarter and Full Year 2023..
1/29/202416:15PRNUSHalozyme Announces Takeda Received European Commission..
1/23/202411:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/18/202416:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202408:30PRNUSHalozyme Announces argenx Received Approval in Japan for..
1/17/202416:56EDGAR2Form 144 - Report of proposed sale of securities
1/17/202408:10EDGAR2Form 8-K - Current report
1/16/202416:26EDGAR2Form 144 - Report of proposed sale of securities
1/16/202408:15PRNUSHalozyme Announces Takeda Receives FDA Approval for HYQVIA®..
1/16/202401:15PRNUSHalozyme Announces Roche Receives European Commission..
1/12/202409:25PRNUSHalozyme to Host Investor Business Forum and Long-Term..
1/05/202416:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202316:40EDGAR2Form 144 - Report of proposed sale of securities
12/12/202316:21EDGAR2Form 144 - Report of proposed sale of securities
11/27/202308:00PRNUSHalozyme to Present at Upcoming Investor Conferences
11/16/202316:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/16/202309:00PRNUSHalozyme Announces argenx Receives European Commission..

Your Recent History

Delayed Upgrade Clock